NLRP3 and inflammatory bowel disease: NLRP3 transcription was found to be highly upregulated in IBD patients, and aberrant activation of the NLRP3 inflammasome has also been observed and associated with an increased risk of IBD pathogenesis (Perera et al., 2018; Chen et al., 2021).